Quetiapine Fumarate 25mg Tab
Tender Title | Quetiapine Fumarate 25mg Tab | ||
Tender ID | 2024_BHEL_39237_1 | Tender Reference Number | 58 H/ MDX/4/0058M2 |
Tender Type | Limited | ||
Tender Opening Date | 2024-08-23 07:30 AM | Tender Closing Date | 2024-09-03 10:00 AM |
Tender Value | Refer Document | Tender Location | Main Hospital, Bhel, Haridwar Uttarakhand , Haridwar , Uttar Pradesh |
Tender Category | Goods | Product Category | Healthcare and Medicine Tenders |
ePublished Date | 2024-08-23 07:30 AM | Bid Opening Date | 2024-09-03 10:30 AM |
Document Download Start Date | 2024-08-23 07:30 AM | Document Download End Date | 2024-09-03 10:00 AM |
Bid Submission Start Date | 2024-08-23 07:30 AM | Bid Submission End Date | 2024-09-03 10:00 AM |
Clarification start Date | Clarification End Date | ||
Bid Validity Period (in Days) | 90 |
Tender Fee | Refer document |
EMD (Earnest Money Deposit) | Refer document |
EMD Fee Type | Fixed |
Payment Instruments/Mode | Not Applicable |
Work Description - Quetiapine Fumarate 25mg Tab
Bharat Heavy Electricals Limited (BHEL), a Public Sector Undertaking, invites limited tenders for the supply of Quetiapine Fumarate 25mg tablets. The tender, with reference number 58 H/ MDX/4/0058M2, is being managed by Jay Kumar at the Main Hospital, BHEL, Haridwar, Uttarakhand. The tender documents can be downloaded from the eProcurement portal starting August 23, 2024, at 1:00 PM until September 3, 2024, at 3:30 PM. The deadline for bid submission is September 3, 2024, at 3:30 PM, with bid opening scheduled for 4:00 PM on the same day. Interested parties are requested to refer to the tender documents for detailed specifications, terms, and conditions.
Office Inviting Bids | Jay Kumar |
Address | Main Hospital, Bhel, Haridwar Uttarakhand |
Contact Details | NA |
NA | |
Website | NA |
(1) Quetiapine Fumarate 25mg. Tab./cap. (2) Clindamycin 600mg. Inj. With Diluent (3) Ondansetron 2mg/5ml Suspension 30ml. Phial..read more
Quetiapine Fumarate 50mg. Tab./cap. (irp No - 00957 As Per Drg.no. 957.0..read more